Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
172
datasets available to search
ShareScore release 0.9.0
Dataset results
172 results for “DNA markers”
Circulating Tumor DNA as Marker for Response to Antineoplastic Treatment of Metastatic Cancer (FLUIDO)
ClinicalTrials.gov study NCT04793061. IPD Sharing: NO. Countries: 1. Publications: 0.
Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma
ClinicalTrials.gov study NCT03302884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
ClinicalTrials.gov study NCT07310446. IPD Sharing: NO. Countries: 1. Publications: 0.
The Utility of Cell-free DNA Methylation Markers for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05573217. IPD Sharing: NO. Countries: 1. Publications: 0.
Circulating Tumour DNA (ctDNA) as a Prognostic and Predictive Marker in Colorectal Cancer - a Pilot Study
ClinicalTrials.gov study NCT04726800. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
ClinicalTrials.gov study NCT03108885. IPD Sharing: NO. Countries: 1. Publications: 0.
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
ClinicalTrials.gov study NCT02503696. IPD Sharing: NO. Countries: 2. Publications: 0.
Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population
ClinicalTrials.gov study NCT01793207. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
ClinicalTrials.gov study NCT02410603. IPD Sharing: NO. Countries: 1. Publications: 0.
Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer
ClinicalTrials.gov study NCT03691012. IPD Sharing: NO. Countries: 2. Publications: 0.
The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor
ClinicalTrials.gov study NCT06863844. IPD Sharing: NO. Countries: 1. Publications: 0.
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer
ClinicalTrials.gov study NCT05826964. IPD Sharing: NO. Countries: 1. Publications: 0.
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
ClinicalTrials.gov study NCT06339138. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer
ClinicalTrials.gov study NCT06600802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients
ClinicalTrials.gov study NCT03881384. IPD Sharing: NO. Countries: 1. Publications: 0.
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
ClinicalTrials.gov study NCT06304168. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT03214991. IPD Sharing: NO. Countries: 1. Publications: 0.
DNA Methylation Markers in Veterans Exposed to Open Burn Pits
ClinicalTrials.gov study NCT06305091. IPD Sharing: NO. Countries: 1. Publications: 0.
The Framingham Study: Examining DNA Markers and Links to Diseases
ClinicalTrials.gov study NCT00062777. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single Cell Transcriptomics of Bone Marrow Derived Macrophages reveal Ccl5 as a marker of Direct IFNAR-independent Responses to DNA Sensing
GEO Series GSE229311. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.